Literature DB >> 14522076

GCF2: expression and molecular analysis of repression.

Toshiki Rikiyama1, Joseph Curtis, Masaya Oikawa, Drazen B Zimonjic, Nicholas Popescu, Barbara A Murphy, Melissa A Wilson, Alfred C Johnson.   

Abstract

GC-binding factor 2 (GCF2) is a transcriptional repressor that decreases activity of the epidermal growth factor receptor (EGFR) and other genes. We have mapped the gene for GCF2 by fluorescence in situ hybridization (FISH) to chromosome 2q37. Sequence analysis of the GCF2 gene and cDNA showed that the gene consists of eight exons and introns and spans 73 kbp of DNA. Northern blot analysis showed that GCF2 mRNA was differentially expressed in many human tissues and cell lines. GCF2 mRNA was expressed as a 4.2 kb mRNA in most human tissues with the highest expression level in peripheral blood leukocytes and lowest expression in brain and testis. Additional transcripts of 6.6, 2.9 and 2.4 kb were found in some tissues but the only transcript detected in cancer cell lines was 4.2 kb with high levels found in seven Burkitts' lymphoma cell lines. Western blot analysis showed that GCF2 protein is present at high levels in Burkitts' lymphoma and several other cancer cell lines. GCF2 was found in both nuclear and cytoplasmic compartments in cells. Deletion mutants of GCF2 revealed that amino acids 429-528 are required for both DNA binding and repression of the EGFR promoter. Furthermore, GCF2 was able to substantially decrease activator protein 2 (AP2) enhancement of the EGFR promoter. Thus, GCF2 is a transcriptional repressor overexpressed in cancer cell lines with a role in regulating expression of the EGFR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522076     DOI: 10.1016/s0167-4781(03)00156-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.

Authors:  Asen Bagashev; Michael C Fitzgerald; David F Larosa; Patrick P Rose; Sara Cherry; Alfred C Johnson; Kathleen E Sullivan
Journal:  J Interferon Cytokine Res       Date:  2010-06-29       Impact factor: 2.607

2.  Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7.

Authors:  V Rocher-Ros; S Marco; J-H Mao; S Gines; D Metzger; P Chambon; A Balmain; C A Saura
Journal:  Oncogene       Date:  2010-03-08       Impact factor: 9.867

3.  Noncoding RNAs and LRRFIP1 regulate TNF expression.

Authors:  Lihua Shi; Li Song; Michael Fitzgerald; Kelly Maurer; Asen Bagashev; Kathleen E Sullivan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

4.  Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.

Authors:  Jamie O Dyer; Arnob Dutta; Madelaine Gogol; Vikki M Weake; George Dialynas; Xilan Wu; Christopher Seidel; Ying Zhang; Laurence Florens; Michael P Washburn; Susan M Abmayr; Jerry L Workman
Journal:  J Mol Biol       Date:  2016-10-27       Impact factor: 5.469

5.  Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions.

Authors:  Chi Young Ok; Zijun Y Xu-Monette; Ling Li; Ganiraju C Manyam; Santiago Montes-Moreno; Alexandar Tzankov; Carlo Visco; Karen Dybkær; Mark J Routbort; Li Zhang; April Chiu; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; William W L Choi; J Han van Krieken; Jooryung Huh; Maurilio Ponzoni; Andrés J M Ferreri; Ben M Parsons; Huilan Rao; Michael B Møller; Jane N Winter; Miguel A Piris; Sa A Wang; L Jeffrey Medeiros; Ken H Young
Journal:  Mod Pathol       Date:  2015-06-26       Impact factor: 7.842

6.  Molecular analysis of ex-vivo CD133+ GBM cells revealed a common invasive and angiogenic profile but different proliferative signatures among high grade gliomas.

Authors:  Juan L Garcia; Maria Perez-Caro; Juan A Gomez-Moreta; Francisco Gonzalez; Javier Ortiz; Oscar Blanco; Magdalena Sancho; Jesus M Hernandez-Rivas; Rogelio Gonzalez-Sarmiento; Manuel Sanchez-Martin
Journal:  BMC Cancer       Date:  2010-08-24       Impact factor: 4.430

Review 7.  Transcriptional down-regulation of epidermal growth factor (EGF) receptors by nerve growth factor (NGF) in PC12 cells.

Authors:  Gadi Cohen; Keren Ettinger; Shimon Lecht; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2014-07-31       Impact factor: 3.444

8.  The transcription factor GCF2 is an upstream repressor of the small GTPAse RhoA, regulating membrane protein trafficking, sensitivity to doxorubicin, and resistance to cisplatin.

Authors:  Ding-Wu Shen; Lynn M Pouliot; Jean-Pierre Gillet; Wenting Ma; Alfred C Johnson; Matthew D Hall; Michael M Gottesman
Journal:  Mol Pharm       Date:  2012-05-17       Impact factor: 4.939

9.  Alternative polyadenylation of tumor suppressor genes in small intestinal neuroendocrine tumors.

Authors:  Anders Rehfeld; Mireya Plass; Kristina Døssing; Ulrich Knigge; Andreas Kjær; Anders Krogh; Lennart Friis-Hansen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-04-15       Impact factor: 5.555

10.  A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke.

Authors:  Judith Mallolas; Olivia Hurtado; Mar Castellanos; Miguel Blanco; Tomás Sobrino; Joaquín Serena; José Vivancos; José Castillo; Ignacio Lizasoain; María A Moro; Antoni Dávalos
Journal:  J Exp Med       Date:  2006-03-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.